The trademark application omvoh was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on December 20, 2021, and it was registered by office on March 29, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of inflammatory bowel disease and autoimmune diseases and disorders and pharmaceutical preparations..
The mark was filed in class 44 with Medical information services in the field of inflammatory bowel disease and autoimmune diseases and disorders and medical information services..